Godfraind T, Salomone S, Dessy C, Verhelst B, Dion R, Schoevaerts J C
Laboratoire de Pharmacologie, Université Catholique de Louvain, Brussels, Belgium.
J Cardiovasc Pharmacol. 1992;20 Suppl 5:S34-41.
The inhibitory effect of calcium antagonists has been studied on the calcium signal and on contractile activity in the human coronary and internal mammary arteries. We observed that rhythmic vasospasms, either spontaneous or evoked by serotonin and endothelin, were highly sensitive to calcium-channel inhibitors. Functional parameters describing the inhibition have been compared to binding parameters estimated in radioligand studies on membranes prepared from human coronary artery and from human heart. Taking the present studies and observations already published together, it was possible to build up a selectivity scale for diltiazem, verapamil, nifedipine, and nisoldipine. This showed that nisoldipine was more selective for coronary artery than the other calcium antagonists so far studied. Such a selectivity observed in functional studies on intact human preparations in vitro could be predicted considering the kinetic parameters of the interaction of nisoldipine with calcium channels.
已经研究了钙拮抗剂对人体冠状动脉和乳内动脉中钙信号及收缩活性的抑制作用。我们观察到,无论是自发的还是由血清素和内皮素诱发的节律性血管痉挛,对钙通道抑制剂都高度敏感。已将描述抑制作用的功能参数与在用人冠状动脉和人心脏制备的膜上进行的放射性配体研究中估计的结合参数进行了比较。综合目前的研究及已发表的观察结果,有可能建立地尔硫卓、维拉帕米、硝苯地平及尼索地平的选择性量表。这表明,与迄今研究的其他钙拮抗剂相比,尼索地平对冠状动脉更具选择性。考虑到尼索地平与钙通道相互作用的动力学参数,可以预测在体外完整人体制剂的功能研究中观察到的这种选择性。